Lv31
220 积分 2026-08-09 加入
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes
29天前
已关闭
SGLT2 Inhibitors vs GLP-1 Receptor Agonists for Kidney Outcomes in Individuals With Type 2 Diabetes
1个月前
已完结
SGLT2 Inhibitors vs GLP-1 Receptor Agonists for Kidney Outcomes in Individuals With Type 2 Diabetes
1个月前
已完结